口吃治療藥物全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測

預計在 2023-2030 研究期間，全球對口吃藥物市場的需求將從 2022 年的 460.9 億美元增長到 2030 年的近 1409.8 億美元，複合年增長率為 15%。

口吃藥物是指旨在提高口吃者流利程度和溝通技巧的各種治療和乾預措施。 口吃是一種言語障礙，會影響言語流暢、聲音和單詞的重複、聲音的延長、阻塞和不自主的停頓。 口吃治療有幾種方法，包括言語治療、行為治療、認知治療、流利治療和口吃矯正治療。

市場動態：

口吃的患病率估計約佔世界人口的 1%，並且男性比女性更常見。 隨著世界人口的增長，預計口吃人數也會增加，從而推動對口吃藥物的需求。 隨著口吃越來越被認可和接受為一種殘疾，口吃的人越來越願意談論他們的經歷並尋求治療，這導致對口吃藥物的需求增加。 口吃藥物的開發取得了很大進步，包括使用電子設備、藥物和言語治療技術。 這些進步帶來了更有效的治療方法，並推動了對口吃藥物的需求。

這份研究報告解釋了波特的五力模型、市場吸引力分析和價值鏈分析。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外，這些工具還能夠全面評估全球口吃藥物市場的各個細分市場。 口吃藥物行業的發展和趨勢為這項研究提供了一個整體的方法。

市場細分：

口吃藥市場報告的這一部分提供了有關國家/地區級別細分市場的詳細數據，從而幫助戰略家確定其各自產品或服務的目標人群並抓住未來機會。以支持

通過治療

• 言語治療
• 口吃
• 認知行為療法 (CBT)
• 親子互動
• 藥物治療

按類型

• 發育性口吃
• 神經性口吃

由最終用戶

• 醫院
• 專科門診
• 家庭護理

按地區分析：

本部分介紹了區域前景，重點關注北美、歐洲、亞太地區、拉丁美洲、中東和非洲目前和未來對口吃藥物市場的需求。 它還側重於所有主要地區的各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 口吃藥物市場的主要參與者是競爭對手 Deep Dive、Auspex Pharmaceuticals Inc.、GlaxoSmithKline plc.、Johnson & Johnson Services、Merck & Co. Inc.、Pfizer Inc.、Siemens Healthcare GmbH、Novartis AG、AstraZeneca、AbbVie Inc.。該部分包含完整的競爭格局圖，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。

內容

第一章前言

• 本報告的內容
  • 目的
  • 目標受眾
  • 獨特的銷售建議 (USP) 和提供的服務
• 調查範圍
• 調查方法
  • 市場調研過程
  • 市場研究方法

第 2 章執行摘要

• 市場亮點
• 全球市場概況

第 3 章口吃藥物 - 行業分析

• 簡介 - 市場動態
• 市場驅動力
• 市場製約因素
• 市場機會
• 行業趨勢
• 波特的五力分析
• 市場吸引力分析
  • 按處理方法進行市場吸引力分析
  • 按類型進行市場吸引力分析
  • 市場吸引力分析：按最終用戶
  • 市場吸引力分析：按地區

第四章價值鏈分析

• 價值鏈分析
• 原材料分析
  • 原材料清單
  • 原材料製造商列表
  • 主要原材料價格走勢
• 潛在買家名單
• 營銷渠道
  • 直接營銷
  • 間接營銷
  • 營銷渠道趨勢

第 5 章治療口吃藥物的全球市場分析

• 按治療方法彙總
• 實際數據和預測數據
• 按治療方法分析
• 語音治療
• 口吃治療儀
• 認知行為療法
• 親子互動
• 藥物治療

第 6 章按類型分列的口吃藥物的全球市場分析

• 按類型概述
• 實際數據和預測數據
• 按類型分析
• 發育性口吃
• 神經性口吃

第 7 章全球口吃藥物市場分析：按最終用戶分類

• 最終用戶總結
• 實際數據和預測數據
• 最終用戶分析
• 醫院
• 專科診所
• 家庭護理

第 8 章口吃藥物的全球市場分析：按地區

• 區域展望
• 簡介
• 北美銷售分析
  • 概述、銷售業績和預測分析銷售分析
  • 北美各部門的銷售分析
  • 北美銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、銷售業績和預測分析銷售分析
  • 按細分市場進行的歐洲銷售分析
  • 按國家/地區劃分的歐洲銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 意大利銷售分析
  • 俄羅斯銷售分析
  • 其他歐洲銷售分析
• 亞太地區銷售分析
  • 概述、銷售業績和預測分析銷售分析
  • 亞太地區各部門的銷售分析
  • 亞太國家/地區銷售分析
  • 在中國的銷售分析
  • 印度銷售分析
  • 日本的銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 其他亞太地區銷售分析
• 拉丁美洲銷售分析
  • 概述、銷售業績和預測分析銷售分析
  • 拉丁美洲各部門的銷售分析
  • 拉丁美洲國家/地區的銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利的銷售分析
  • 其他拉丁美洲銷售分析
• 中東和非洲銷售分析
  • 概述、銷售業績和預測分析銷售分析
  • 中東/非洲地區的銷售分析
  • 中東和非洲國家/地區的銷售分析
  • 沙特阿拉伯銷售分析
  • 阿聯酋銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 其他中東和非洲銷售分析

第 9 章口吃藥公司的競爭格局

• 口吃藥物的市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第十章公司簡介

• 公司股票分析
• 市場集中度
• 競爭深入研究
  • 公司簡介
  • 企業收入
  • 產品介紹
  • 近期發展狀況
• Auspex 製藥公司
  • 公司簡介
  • 企業收入
  • 產品信息
  • 近期發展狀況
• 葛蘭素史克公司。
  • 公司簡介
  • 企業收入
  • 產品信息
  • 近期發展狀況
• 強生服務
  • 公司簡介
  • 企業收入
  • 產品信息
  • 近期發展狀況
• 默克公司
  • 公司簡介
  • 企業收入
  • 產品信息
  • 近期發展狀況
• 輝瑞公司
  • 公司簡介
  • 企業收入
  • 產品信息
  • 近期發展狀況
• 西門子醫療保健有限公司
  • 公司簡介
  • 企業收入
  • 產品信息
  • 近期發展狀況
• 諾華公司
  • 公司簡介
  • 企業收入
  • 產品信息
  • 近期發展狀況
• 阿斯利康
  • 公司簡介
  • 企業收入
  • 產品信息
  • 近期發展狀況
• 艾伯維公司
  • 公司簡介
  • 企業收入
  • 產品信息
  • 近期趨勢

注意：公司簡介中的財務細節和近期發展基於可用信息，可能不包括私營公司。

The global demand for Stuttering Therapeutics Market is presumed to reach the market size of nearly USD 140.98 BN by 2030 from USD 46.09 BN in 2022 with a CAGR of 15% under the study period 2023 - 2030.

Stuttering therapeutics refers to the various treatments and interventions that aim to help individuals who stutter improve their speech fluency and communication skills. Stuttering is a speech disorder affecting the flow of speech, repetitions of sounds or words, prolongations of sounds, and blocks or involuntary pauses. There are several approaches to stuttering therapeutics, including speech therapy, behavioural therapy, cognitive therapy, fluency shaping therapy, and stuttering modification therapy.

Market Dynamics:

The prevalence of stuttering is estimated to be around 1% of the global population, with the disorder being more common in males than females. As the global population grows, the number of individuals with stuttering is also expected to increase, driving demand for stuttering therapeutics. With growing awareness and acceptance of stuttering as a disorder, individuals with stuttering are becoming more vocal about their experiences and seeking treatment which has assisted in increasing the demand for stuttering therapeutics. There have been significant advancements in the development of stuttering therapeutics, including the use of electronic devices, medications, and speech therapy techniques. These advancements have led to more effective treatment options, driving demand for stuttering therapeutics.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of stuttering therapeutics. The growth and trends of stuttering therapeutics industry provide a holistic approach to this study.

Market Segmentation:

This section of the stuttering therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment

• Speech Therapy
• Stuttering Devices
• Cognitive Behavioural Therapy
• Parent-Child Interaction
• Drug Therapy

By Type

• Developmental Stuttering
• Neurogenic Stuttering

By End User

• Hospitals
• Specialty Clinics
• Homecare

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Stuttering Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the stuttering therapeutics market include Competition Deep Dive, Auspex Pharmaceuticals Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Merck & Co. Inc., Pfizer Inc., Siemens Healthcare GmbH, Novartis AG, AstraZeneca, AbbVie Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . STUTTERING THERAPEUTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Treatment
  • 3.7.2 Market Attractiveness Analysis By Type
  • 3.7.3 Market Attractiveness Analysis By End User
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL STUTTERING THERAPEUTICS MARKET ANALYSIS BY TREATMENT

• 5.1 Overview by Treatment
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Treatment
• 5.4 Speech Therapy Historic and Forecast Sales by Regions
• 5.5 Stuttering Devices Historic and Forecast Sales by Regions
• 5.6 Cognitive Behavioural Therapy Historic and Forecast Sales by Regions
• 5.7 Parent-Child Interaction Historic and Forecast Sales by Regions
• 5.8 Drug Therapy Historic and Forecast Sales by Regions

6 . GLOBAL STUTTERING THERAPEUTICS MARKET ANALYSIS BY TYPE

• 6.1 Overview by Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Type
• 6.4 Developmental Stuttering Historic and Forecast Sales by Regions
• 6.5 Neurogenic Stuttering Historic and Forecast Sales by Regions

7 . GLOBAL STUTTERING THERAPEUTICS MARKET ANALYSIS BY END USER

• 7.1 Overview by End User
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End User
• 7.4 Hospitals Historic and Forecast Sales by Regions
• 7.5 Specialty Clinics Historic and Forecast Sales by Regions
• 7.6 Homecare Historic and Forecast Sales by Regions

8 . GLOBAL STUTTERING THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE STUTTERING THERAPEUTICS COMPANIES

• 9.1. Stuttering Therapeutics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF STUTTERING THERAPEUTICS INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Competition Deep Dive
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Auspex Pharmaceuticals Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. GlaxoSmithKline plc.
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Johnson & Johnson Services
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Merck & Co. Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Pfizer Inc.
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Siemens Healthcare GmbH
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Novartis AG
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. AstraZeneca
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. AbbVie Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Treatment (USD MN)
• Speech Therapy Market Sales by Geography (USD MN)
• Stuttering Devices Market Sales by Geography (USD MN)
• Cognitive Behavioural Therapy Market Sales by Geography (USD MN)
• Parent-Child Interaction Market Sales by Geography (USD MN)
• Drug Therapy Market Sales by Geography (USD MN)
• Analysis Market by Type (USD MN)
• Developmental Stuttering Market Sales by Geography (USD MN)
• Neurogenic Stuttering Market Sales by Geography (USD MN)
• Analysis by End User (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Specialty Clinics Market Sales by Geography (USD MN)
• Homecare Market Sales by Geography (USD MN)
• Global Stuttering Therapeutics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Stuttering Therapeutics Report
• Market Research Process
• Market Research Methodology
• Global Stuttering Therapeutics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Treatment
• Market Attractiveness Analysis by Type
• Market Attractiveness Analysis by End User
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Treatment (USD MN)
• Speech Therapy Market Sales by Geography (USD MN)
• Stuttering Devices Market Sales by Geography (USD MN)
• Cognitive Behavioural Therapy Market Sales by Geography (USD MN)
• Parent-Child Interaction Market Sales by Geography (USD MN)
• Drug Therapy Market Sales by Geography (USD MN)
• Global Market Analysis by Type (USD MN)
• Developmental Stuttering Market Sales by Geography (USD MN)
• Neurogenic Stuttering Market Sales by Geography (USD MN)
• Global Market Analysis by End User (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Specialty Clinics Market Sales by Geography (USD MN)
• Homecare Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.